16 Nisan 2019 Salı

Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns


By HEATHER MURPHY from NYT Health The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. https://nyti.ms/2GlsXBT

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...